Quantification of egg ovalbumin hydrolysate-derived anti-hypertensive peptides in an in vitro model combining luminal digestion with intestinal Caco-2 cell transport.
Food Res Int
; 99(Pt 1): 531-541, 2017 09.
Article
en En
| MEDLINE
| ID: mdl-28784514
Food-derived peptides can impact blood pressure through several mechanisms. However, their fate in the gastro-intestinal tract and bioavailability are difficult to assess because of their fast degradation and challenging analysis in physiologically relevant matrices. The aim of this study was to construct an in vitro bioavailability methodology in which luminal digestion is combined with Caco-2 cell transport. Egg ovalbumin hydrolysate, both in pure form and mixed with a food matrix, was used as a test case. Results indicate that a food matrix protected bioactive peptides from luminal digestion, especially in small intestine. Moreover, the Caco-2 absorption peak was extended over a longer time period (>60min) compared to the pure peptide solutions (~15min) which in total resulted in a 3-12 times higher absorption of the bioactive sequences after 60min compared to fasted conditions. These results suggest further investigation is warranted towards peptide-based functional foods with improved gastro-intestinal stability and longer-term release in the blood.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fragmentos de Péptidos
/
Ovalbúmina
/
Digestión
/
Absorción Intestinal
/
Mucosa Intestinal
/
Antihipertensivos
Límite:
Humans
Idioma:
En
Revista:
Food Res Int
Año:
2017
Tipo del documento:
Article
País de afiliación:
Bélgica
Pais de publicación:
Canadá